Gramicidin is a heterogeneous mixture of antibiotic peptides, primarily produced by Bacillus brevis. It was one of the first antibiotics to be isolated and characterized, discovered by René Dubos in 1939 from a soil bacillus. Its discovery was pivotal in demonstrating the therapeutic potential of antimicrobial compounds derived from microorganisms. Gramicidin is historically significant as it preceded penicillin’s widespread use and was employed topically during World War II to treat wounds. The term ‘gramicidin’ broadly refers to several related peptides, including the linear, channel-forming gramicidins (A, B, C, D) and the cyclic, detergent-like gramicidin S. These peptides are notable for being rich in D-amino acids, a rarity in nature, which contributes to their resistance to proteolytic degradation. Gramicidin’s primary mechanism involves disrupting bacterial cell membranes, making it a classic model system for studying ion channel function and membrane biophysics.
Quick Facts
| Also Known As | Gramicidin D, Gramicidin A, Gramicidin S, Gramicidin J, Tyrocidine |
|---|---|
| Sequence | HCO-L-Val-Gly-L-Ala-D-Leu-L-Ala-D-Val-L-Val-D-Val-L-Trp-D-Leu-L-Trp-D-Leu-L-Trp-D-Leu-L-Trp-NHCH2CH2OH (Gramicidin A, linear form). Sequence varies among isoforms (A, B, C, D, S). |
| Molecular Formula | C99H140N20O17 |
| Molecular Weight | 1882.3 Da |
| PubChem CID | 16130140 |
Research Parameters
| Half-Life | Not applicable for topical/research use. In membrane systems, channel lifetime is on the order of seconds to minutes before dimer dissociation. |
|---|---|
| Stability | Lyophilized powder is stable for years when stored desiccated at -20°C. Solutions in alcohol (e.g., ethanol) are more stable than aqueous solutions. In aqueous buffers or after incorporation into membranes, stability is limited due to aggregation and precipitation; it is typically used immediately in experiments. |
| Solubility | Poorly soluble in pure water. Typically dissolved in ethanol, methanol, dimethyl sulfoxide (DMSO), or trifluoroethanol for stock solutions, which are then diluted into aqueous buffers or lipid dispersions. |
| Vial Size | 10 mg |
| Storage (Lyophilized) | -20°C, desiccated, protected from light. |
| Storage (Reconstituted) | For stock solutions in organic solvent (e.g., ethanol): -20°C for several months. For aqueous working dilutions: prepare fresh and use immediately; do not store. |
| Typical Research Dose | Not applicable for in vivo human dosing. In vitro research concentrations typically range from 0.1 to 100 µg/mL in assay buffers. |
| Cycle Parameters | Not applicable. Research use involves single applications in experimental systems (e.g., adding to cell culture, incorporating into synthetic membranes). |
| Amino Acid Count | 31 |
Mechanism of Action
Gramicidin exerts its antibacterial effects primarily by forming ion channels in lipid bilayers, leading to dissipation of vital ion gradients and ultimately bacterial cell death. The specific mechanism differs between its linear and cyclic forms.
Linear Gramicidin (A, B, C, D) Ion Channel Formation: These peptides are linear pentadecapeptides with alternating D- and L-amino acids. Two monomers dimerize head-to-head (formamido to formamido) via hydrogen bonds within the lipid bilayer to form a hollow, helical β-helix structure. This dimer spans the membrane and acts as a monovalent cation-selective channel, preferentially conducting H+, Na+, and K+ ions. The uncontrolled flux of these ions collapses the transmembrane electrochemical potential, disrupting cellular homeostasis, ATP synthesis, and osmotic balance.
Gramicidin S (Cyclic) Detergent-like Action: Gramicidin S is a cyclic decapeptide with a β-sheet structure. It does not form discrete channels. Instead, it acts like a detergent or surfactant, integrating into bacterial membranes and disrupting their integrity via a 'carpet' or 'toroidal pore' model. This causes generalized membrane permeabilization and leakage of cellular contents.
Membrane Disruption Consequences: Both mechanisms lead to the same ultimate outcome: loss of membrane integrity, collapse of ion gradients, efflux of cellular components, and bacteriolysis. Gramicidin is effective primarily against Gram-positive bacteria due to its inability to traverse the outer membrane of Gram-negative organisms.
Research Applications
Antibacterial Research: Gramicidin remains a fundamental tool in microbiology for studying antibiotic mechanisms of action and bacterial membrane biology. Its ability to selectively kill Gram-positive bacteria makes it a reference compound for evaluating new antimicrobial strategies and understanding resistance mechanisms.
Biophysics and Membrane Studies: Gramicidin A is arguably the most well-characterized model ion channel. It is extensively used in biophysical research to study principles of ion permeation, channel gating kinetics, protein-lipid interactions, and the physical properties of lipid bilayers. Its simple, well-defined structure allows for detailed spectroscopic, electrophysiological, and computational analysis.
Historical and Drug Discovery Research: As one of the first commercial antibiotics, gramicidin's history provides insights into the early era of antibiotic discovery. Research into its biosynthesis, which involves non-ribosomal peptide synthetases (NRPS), contributes to the field of synthetic biology and engineering of novel peptide therapeutics.
Safety & Side Effects
Gramicidin is highly hemolytic, meaning it lyses red blood cells, and is cytotoxic to mammalian cells due to its non-selective membrane-disrupting activity. This systemic toxicity prevents its use as an internal medication. In historical and current topical use (e.g., in first-aid creams or ophthalmic solutions), side effects are rare but can include local irritation, burning, or allergic contact dermatitis. Anecdotal reports from improper use are not documented. The primary theoretical concern is its potent membrane-disrupting property, which makes it dangerous if introduced systemically. Animal studies confirm its acute toxicity upon injection.
Dosage Information
This information is derived from historical clinical use and research contexts only. Gramicidin is NOT for human self-administration and is used in research or in specific, professionally administered topical formulations.
In historical medical use, gramicidin was applied topically as an ointment or solution (often in combination with other antibiotics like neomycin and polymyxin B) for skin and eye infections. Typical research applications involving the peptide itself use it in vitro at concentrations ranging from 0.1 to 100 µg/mL in bacterial culture or membrane model systems. In biophysical studies of channel formation, it is incorporated into lipid vesicles or planar bilayers at very low mole percentages (e.g., 0.01-1 mol% relative to lipid).
References
Dubos, R.J. Studies on a bactericidal agent extracted from a soil bacillus: I. Preparation of the agent. Its activity in vitro. Journal of Experimental Medicine, 70(1), 1-10, 1939.
Killian, J.A. & von Heijne, G. How proteins adapt to a membrane-water interface. Trends in Biochemical Sciences, 25(9), 429-434, 2000.
Andersen, O.S. Gramicidin channels. Annual Review of Physiology, 46, 531-548, 1984.
Sarges, R. & Witkop, B. Gramicidin A. V. The structure of valine- and isoleucine-gramicidin A. Journal of the American Chemical Society, 87(9), 2011-2020, 1965.
Hladky, S.B. & Haydon, D.A. Ion transfer across lipid membranes in the presence of gramicidin A. Biochimica et Biophysica Acta (BBA) - Biomembranes, 274(2), 294-312, 1972.
Konovalov, A. et al. Antimicrobial peptide gramicidin S is accumulated in granules of producer cells for delivery to bacterial predators. Scientific Reports, 8, 14149, 2018.
Ostroumova, O.S. et al. Effect of agents modifying the membrane dipole potential on properties of gramicidin A channels. Langmuir, 27(23), 14354-14361, 2011.